Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,140.49
+24.792.22%
Volume:682.55K
Turnover:778.02M
Market Cap:1.08T
PE:38.29
High:1,153.45
Open:1,142.20
Low:1,130.50
Close:1,115.70
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:1.28
T/O Rate:0.07%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.83
PE(LYR):49.69

Loading ...

Eli Lilly Raises Annual Revenue Forecast as GLP-1 Drugs Fuel Growth

Reuters
·
Aug 05

Novo CEO Looks to Speed up R&D as Share Drop Shows Gap with Lilly

Reuters
·
Aug 05

AMD, Walt Disney And 3 Stocks To Watch Heading Into Wednesday

Benzinga Earnings
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Sandoz Gains on Strong Biosimilar Growth, Touts 'golden Decade'

Reuters
·
Aug 05

Suncoast Equity Management trims Eli Lilly position

TIPRANKS
·
Aug 05

Eli Lilly Could Swing $65.9 Billion After Earnings

Benzinga
·
Aug 05

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Aug 04

Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly

MT Newswires Live
·
Aug 04

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Reuters
·
Aug 04

Believe it is Medically Appropriate to Make Authentic Retatrutide Available Before FDA Approval for Patients Meeting Some Criteria -Lilly Spokesperson

THOMSON REUTERS
·
Aug 04

Eli Lilly tells Stat it will let more patients apply for retatrutide access

TIPRANKS
·
Aug 04

Movement Alert|Eli Lilly Falls 3.21% in Regular Trading, Pipeline Breakthrough Overshadowed by GLP-1 Growth Concerns and Sector Weakness

Market Focus
·
Aug 03

Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Benzinga_recent_news
·
Aug 03

Lilly's Olomorasib Receives U.S. FDA's Breakthrough Therapy Designation for the Treatment of Previously Treated Kras G12c-Mutant Advanced Pancreatic Cancer

THOMSON REUTERS
·
Aug 03

Eli Lilly Stock Leads 3 Pharma Picks As Merger Talk Shakes Big Drugmakers

Simply Wall St.
·
Aug 03

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Jobs Report; Palantir, AMD, SpaceX, and Eli Lilly Earnings Reports: What to Watch This Week

Dow Jones
·
Aug 03

Earning Preview: Eli Lilly Q2 revenue is expected to increase by 40.78%, and institutional views are bullish

Earnings Agent
·
Aug 02

Ratio Therapeutics Announced Closing of a $70 Million Series C Financing

Reuters
·
Jul 31